The AR glasses, together with digital learning modules, allow nurses to learn how to use acute dialysis machines. Credit: Fresenius Medical Care.

Fresenius Medical Care has introduced an augmented reality (AR) application to enhance training for intensive care unit (ICU) nursing staff.

The Ready4 multiFiltratePRO AR application is designed for training on the company’s Continuous Kidney Replacement Therapy system, merging digital learning elements with real-life training.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Together with digital learning modules, the AR glasses allow nurses to learn how to use acute dialysis machines on-site within the wards.

As the user interacts with the dialysis machine, the technology streams visual and audio instructions, facilitating a comprehensive learning process.

Fresenius Medical Care management board member Dr Katarzyna Mazur-Hofsäß said: “We have a dedicated focus on leveraging advanced technology to develop and provide the most innovative technologies, engineered to facilitate and simplify the learning process.

See Also:

“Our innovative solution is designed to ensure that nursing staff, particularly those in Intensive Care Units, are equipped with the knowledge needed to provide high-quality and exceptional patient care.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Fresenius Medical Care plans to launch the application in select markets by the second quarter of 2024, with a broader release in the Europe, Middle East, Africa, and Asia Pacific regions to follow.

The application is tailored for use with the multiFiltratePRO Continuous Kidney Replacement Therapy system, currently operational in more than 40 countries worldwide.

The company plans for a limited launch of the multiFiltratePRO system in the US later this year.

A full launch, including the Ready4 multiFiltratePRO AR experience, is contingent on the successful outcome of the Safety of Regional Citrate Anticoagulation (SARCA) trial and is scheduled for 2025. 

The AR training tool was showcased at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) in Brussels.

Last month, PatenSee agreed to conduct a multi-centre pilot trial of its contactless monitoring system within Fresenius Medical Care’s dialysis clinics in Israel.